Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - dl-alpha-tocopherol, quantity: 0.64 mg/ml; retinol palmitate, quantity: 135.3 microgram/ml; phytomenadione, quantity: 20 microgram/ml; ergocalciferol, quantity: 1 microgram/ml - injection, concentrated - excipient ingredients: sodium hydroxide; water for injections; glycerol; egg lecithin; soya oil - vitalipid n infant is indicated as a supplement in complete intravenous nutrition to meet the daily requirements of the fat- soluble vitamins a, d2, e and k1 in paediatric patients up to 11 years of age.

New Zealand - English - Medsafe (Medicines Safety Authority)

fresenius kabi new zealand limited - dl-alpha tocopherol 0.64 mg/ml;  ; ergocalciferol 1 µg/ml; phytomenadione 20 µg/ml; retinol palmitate 135.3 µg/ml (corresponding to 69 ug retinol) - emulsion for injection - active: dl-alpha tocopherol 0.64 mg/ml   ergocalciferol 1 µg/ml phytomenadione 20 µg/ml retinol palmitate 135.3 µg/ml (corresponding to 69 ug retinol) excipient: egg lecithin glycerol sodium hydroxide soya oil water for injection - vitalipid n infant is indicated in paediatric patients up to 11 years of age as a supplement in complete intravenous nutrition to meet the daily requirements of the fat-soluble vitamins a, d2, e and k1.

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - phytomenadione, quantity: 15 microgram/ml; ergocalciferol, quantity: 0.5 microgram/ml; retinol palmitate, quantity: 194.1 microgram/ml; dl-alpha-tocopherol, quantity: 0.91 mg/ml - injection, concentrated - excipient ingredients: soya oil; egg lecithin; glycerol; water for injections; sodium hydroxide - vitalipid n adult is indicated as a supplement in complete intravenous nutrition to meet the daily requirements of the fat- soluble vitamins a, d2, e and k1.

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi deutschland gmbh - ergocalciferol; phytomenadione; retinol palmitate; dl-alpha-tocopherol - concentrate for emulsion for infusion - 10 millilitre(s) - vitamins

New Zealand - English - Medsafe (Medicines Safety Authority)

fresenius kabi new zealand limited - dl-alpha tocopherol 0.91 mg/ml;  ; ergocalciferol 0.5 µg/ml; phytomenadione 15 µg/ml; retinol palmitate 194.1 µg/ml (corresponding to 99 ug retinol) - emulsion for injection - active: dl-alpha tocopherol 0.91 mg/ml   ergocalciferol 0.5 µg/ml phytomenadione 15 µg/ml retinol palmitate 194.1 µg/ml (corresponding to 99 ug retinol) excipient: egg lecithin glycerol sodium hydroxide soya oil water for injection - vitalipid n adult is indicated as a supplement in complete intravenous nutrition to meet the daily requirements of the fat-soluble vitamins a, d2, e and k1.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

fatro s.p.a. - dl-alpha-tocopherol acetate 50% - unknown - dl-alpha-tocopherol acetate 50% vitamin-e active 0.0 - active constituent

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi deutschland gmbh - retinol palmitate; ergocalciferol; dl-alpha-tocopherol; phytomenadione - concentrate for emulsion for infusion - 10 millilitre(s) - vitamins

Malta - English - Medicines Authority

fresenius kabi limited - phytomenadione; dl-alfa-tocopherol; ergocalciferol; retinol - emulsion for infusion - phytomenadione 20 µg/ml; dl-alfa-tocopherol 0.64 mg/ml; ergocalciferol 1 µg/ml; retinol 69 µg/ml - blood substitutes and perfusion solutions

Malta - English - Medicines Authority

fresenius kabi italia s.r.l via camagre 41, 37063 isola della scala (vr) , italy - phytomenadione, dl, alfa, tocopherol, ergocalciferol, retinol - emulsion for infusion - phytomenadione 20 µg/ml dl-alfa-tocopherol 0.64 mg/ml ergocalciferol 1 µg/ml retinol 69 µg/ml - blood substitutes and perfusion solutions

Israel - English - Ministry of Health

cure medical & technical supply - ergocalciferol; phytomenadione; retinol palmitate; tocopherol - concentrate for solution for infusion - phytomenadione 20 mcg/ml; ergocalciferol 1 mcg/ml; tocopherol 0.64 mg/ml; retinol palmitate 135.3 mcg/ml - combinations of electrolytes - combinations of electrolytes - vitalipid n infants is indicated in infants and children up to 11 years of age as a supplement in iv nutrition to meet the daily requirement of the fat soluble vitamins a, d2, e,k1.